Sharpe-Strumia Research Foundation
About
The mission of the Sharpe-Strumia Research Foundation is to encourage and support the conduct of medical research by practicing physicians on the medical staff of Main Line Hospitals with preference given to physicians whose primary hospital affiliation is the Bryn Mawr Campus, and to research which relates to identified clinical initiatives at the Bryn Mawr campus and Main Line Hospitals.
Collaborative studies with outside individuals or institutions (with preference given to other Jefferson Health System campuses) are encouraged, provided that such studies include active involvement of the practicing physician-investigator and are likely to lead to clinical trials at the Bryn Mawr or other Main Line Hospital campuses.
Contact us:
130 South Bryn Mawr Avenue
C-Wing, 6th Floor, Room 650
Bryn Mawr, PA 19010
Phone: 484.337.4244 | Fax: 484.337.4245
MyChart Privacy Policy
Main Line Health's chargemaster does not include services provided by physicians or advanced practice providers, who treat you while you are at the hospital or outpatient setting. You may receive separate bills from the doctors involved in your care.
MyChart is owned and operated by Main Line Health and is fully compliant with federal and state laws pertaining to your privacy. Your name and email address will be treated with the same care and privacy given your health records and will never be sold or leased by Main Line Health. Read the full Privacy Policy.
MyChart security
We take great care to ensure your health information is kept private and secure. Access to information is controlled through secure activation codes, personal usernames and passwords. You control your own password, and the account cannot be accessed without that password.
In addition, MyChart also uses the latest 128-bit SSL encryption technology with no caching to automatically encrypt your session. Unlike conventional email, all MyChart messaging is done while you are securely logged on to our website.
Bryn Mawr Hospital
SSRF2022-01 / Michele Columbo: Asthma in the elderly: a double-blind, placebo controlled, cross over study of the effect of probiotics.
SSRF2022-09 / Michael D. Ezekowitz: Developing a protocol and initiating a pilot study for a prospective randomized comparison of the four approved direct-acting oral anticoagulants in elderly patients with atrial fibrillation.
SSRF2022-16 / Ashlie Burkart: Spatial Transcriptomics of Leaky Gut
SSRF2022-19 / Glen Harper: Retrospective analysis to compare the use of high and low dose DOACs and patient not being anticoagulated with atrial fibrillation age 80 and above in the BMMSA database
Lankenau Institute of Medical Research
SSRF2022-03 / Sunil Thomas, MD: Development of MNRNA BINI therapy for the treatment of ulcerative colitis
SSRF2022-04 / Laura Mandik-Navak, MD: Unraveling the mechanism by which subtherapeutic antibody targeting of IDO2 alleviates autoimmune arthritis
SSRF2022-05 / Gan-Xin Yan, MD: Inverse Decremental Conduction and High Degree AV Block Following Transcatheter Aortic Valve Replacement.
SSRF2022-06 / Susan Gilmour: Biomarkers for neutrophil extracellular trap formation in ovarian cancer patient
SSRF2022-07 / Lisa Laury-Kleintop: Understanding the internalization of a novel therapeutic antibody for treating autoimmunity.
SSRF2022-08 / U. Margaretha Wallon: Retro- and prospective study of blood based assay as biomarker for CIPN [chemotherapy induced peripheral neuropathy]
SSRF2022-10 / Basel Ramlawi: Main Line Advanced Valve and Aortic Center Clinical Outcome Review: focus in intervention for aortic and mitral valve disease
SSRF2022-11 / Serge Sicouri: Cost analysis comparison of distinct aortic, mitral and coronary interventions at Lankenau Medical Center
SSRF2022-12 / Hector Barajas-Martinez: Pharmacogenomics in novel calcium channel mutations in Brugada and Atrial Fibrillation linked with sudden cardiac death syndromes
SSRF2022-13 / Eric Alexander: Polyamine and GCN2-related biomarkers in cancer patients treated with immunotherapy
SSRF2022-14 / James Mullin, PhD: Decreasing Upper Gastrointestinal mucosal leak by orally administered zinc
SSRF2022-17 / Scott Dessain: An anti-cancer monoclonal antibody cocktail that blocks NMDA receptor function
Board members
Jack L. Martin, MD
President 2016–Present
Vice President 2014–2016
President 1998–2008
Guy T. Bernstein, MD
Vice President
Barbara S. Lindsay, MSN, RN
Treasurer and Secretary
Mike Buongiorno
Executive VP, Finance/CFO, Main Line Health
Ex-Officio
Lawrence L. Livornese, Jr., MD
Chairman of Medicine, Main Line Health
Ex-Officio
John T. Schwarz
President, Bryn Mawr Hospital
Ex-Officio
Gary H. Friday, MD
Louise Gethers, Office Secretary
Foundation Accountant
MyChart Privacy Policy
Main Line Health's chargemaster does not include services provided by physicians or advanced practice providers, who treat you while you are at the hospital or outpatient setting. You may receive separate bills from the doctors involved in your care.
MyChart is owned and operated by Main Line Health and is fully compliant with federal and state laws pertaining to your privacy. Your name and email address will be treated with the same care and privacy given your health records and will never be sold or leased by Main Line Health. Read the full Privacy Policy.
MyChart security
We take great care to ensure your health information is kept private and secure. Access to information is controlled through secure activation codes, personal usernames and passwords. You control your own password, and the account cannot be accessed without that password.
In addition, MyChart also uses the latest 128-bit SSL encryption technology with no caching to automatically encrypt your session. Unlike conventional email, all MyChart messaging is done while you are securely logged on to our website.